Evaluation of Carcinogenic Risks to Humans
Evaluation of Carcinogenic Risks to Humans
批准号:
10229197
负责人:
MARY K. SCHUBAUER-BERIGAN
金额:
$90.02万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 2021-08-31
关键词:
AchievementAnimalsBiological ProductsCancer ControlCarcinogenesis MechanismCarcinogensCharacteristicsChemicalsCollaborationsCommunitiesComplex MixturesConflict of InterestConsensusCountryDataDatabasesDocumentationEnsureEnvironmental and Occupational ExposureEvaluationExposure toFreedomFundingFutureGoalsGovernmentGuidelinesHazard IdentificationHealthHumanIncomeInternationalInternational Agency for Research on CancerLiteratureMalignant NeoplasmsMeasuresMethodologyMethodsMonographNational Toxicology ProgramPreventable cancer causeProceduresProcessPublic HealthPublicationsResearchRiskScienceSocial NetworkSourceTechnologyTest ResultTimeU-Series Cooperative AgreementsWeightWorld Health Organizationanticancer researchbasecarcinogenicitydata streamsdigitalevidence baseexperienceexposed human populationhealth assessmentimprovedinterestlifestyle factorslow and middle-income countriesmeetingsnewsnovelpreventprogramspublic health relevancesystematic reviewtoolweb-based toolworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The IARC Monographs on the Evaluation of Carcinogenic Risks to Humans is an international evidence-based approach to carcinogen hazard identification initiated in 1971. The overall objective is to identify preventable causes o cancer. This is advanced by conducting authoritative evaluations of suspected carcinogens and disseminating the results through multiple media. Because a broad range of exposures may contribute to human cancer, carcinogen evaluations encompass environmental and occupational exposures, physical and biological agents, chemicals, complex mixtures and lifestyle factors. Almost 1000 agents have been evaluated to date, with 114 classified as carcinogenic and 352 as probably or possibly carcinogenic to humans. Agents are selected for evaluation based on evidence of human exposure, suspicion of carcinogenicity, and public health importance. Each IARC Monograph includes systematic reviews of the pertinent scientific literature and an evaluation of the weight of the evidence that an agent or exposure may be carcinogenic to humans. Monographs are developed by Working Groups selected on the principles of including the best-qualified experts and avoiding conflicts of interest. Nationa and international health agencies use the IARC Monographs as a trustworthy source of scientific information and as the scientific basis for their efforts to control cancer. The specifc aims of this project are to: organize at least 10 Monograph meetings to evaluate candidate carcinogenic agents of high global relevance and concern; convene Working Groups that are scientifically rigorous, respected, and free of conflict of interest; enhance the systematic search evaluation and documentation of scientific data for carcinogen evaluations; advance the use of mechanistic data in carcinogen evaluations; promote wide dissemination of evaluation results and engage in collaborations with national and international organizations to improve the science and practice of evaluating potential carcinogens. Important new initiatives in the proposed project period are to: expand the spectrum of mechanistic data considered in making evaluations to additional data streams, such as high-throughput test results; further systematize the review of mechanistic data according to key characteristics of carcinogens; introduce new working procedures and Web-based tools to enhance the documentation of the search for and evaluation of relevant literature on cancer in humans, cancer in experimental animals, and relevant mechanisms.
期刊论文(112)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Carcinogenicity of some industrial chemical intermediates and solvents.
一些工业化学中间体和溶剂的致癌性。
DOI:
10.1016/s1470-2045(19)30779-x
发表时间:
2020
期刊:
The Lancet. Oncology
影响因子:
--
作者:
[IARCMonographsVol125group]
通讯作者:
IARCMonographsVol125group
Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite.
蒽、2-溴丙烷、甲基丙烯酸丁酯和亚磷酸氢二甲酯的致癌性。
DOI:
10.1016/s1470-2045(23)00141-9
发表时间:
2023
期刊:
The Lancet. Oncology
影响因子:
--
作者:
[Cattley,RussellC, Kromhout,Hans, Sun,Meng, Tokar,ErikJ, Abdallah,MohamedA-E, Bauer,AlisonK, Broadwater,KendraR, Campo,Laura, Corsini,Emanuela, Houck,KeithA, Ichihara,Gaku, Matsumoto,Michiharu, Morais,Simone, Mráz,Jaroslav, Nomiyama,Te]
通讯作者:
Nomiyama,Te
Post-menopausal oestrogen-progestogen therapy.
绝经后雌激素-孕激素治疗。
DOI:
--
发表时间:
1999
期刊:
IARC monographs on the evaluation of carcinogenic risks to humans
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/s1470-2045(23)00622-8
发表时间:
2024
期刊:
The Lancet. Oncology
影响因子:
--
作者:
[Zahm,Shelia, Bonde,JensPeter, Chiu,WeihsuehA, Hoppin,Jane, Kanno,Jun, Abdallah,Mohamed, Blystone,ChadR, Calkins,MiriamM, Dong,Guang-Hui, Dorman,DavidC, Fry,Rebecca, Guo,Huan, Haug,LineS, Hofmann,JonathanN, Iwasaki,Motoki, Machala,Mi]
通讯作者:
Machala,Mi
Dichloroacetic acid.
二氯乙酸。
DOI:
--
发表时间:
1995
期刊:
IARC monographs on the evaluation of carcinogenic risks to humans
影响因子:
--
作者:
[]
通讯作者:
共 89 条
IARC Monographs on the Identification of Carcinogenic Hazards to Humans
-
批准号:10319666
-
项目类别:
-
资助金额:$98.03万
-
财政年份:1985
-
负责人:MARY K. SCHUBAUER-BERIGAN
-
依托单位:
IARC Monographs on the Identification of Carcinogenic Hazards to Humans
-
批准号:10460571
-
项目类别:
-
资助金额:$97.04万
-
财政年份:1985
-
负责人:MARY K. SCHUBAUER-BERIGAN
-
依托单位:
Evaluation of Carcinogenic Risks to Humans
-
批准号:9762845
-
项目类别:
-
资助金额:$89.4万
-
财政年份:1985
-
负责人:MARY K. SCHUBAUER-BERIGAN
-
依托单位:
海外基金